08:30 - 10:00
![Interpretation](i/i_icon/d_j_to_e.gif)
![Interpretation](i/i_icon/d_e_to_j.gif)
![Interpretation](i/i_icon/d_to_c.gif)
PCI in general
Co-sponsored by TOSHIBA MEDICAL SYSTEMS CORPORATION
Room 9
Kobe International Exhibition Hall 3
Chair(s): Ji Yan Chen, Junbo Ge, Yong Huo, Yoshio Kobayashi, Eisho Kyo
Discusser(s): Toshiya Muramatsu
Lecturer(s):
Lecture on
Opening remarks
:
Yong Huo
Could DTB time be shortened in China?: From STEMI China to STEMI Guang Zhou :
Ji Yan Chen
Intensive statin therapy for Chinese patients with coronary artery disease undergoing percutaneous coronary intervention, the ISCAP study :
Yong Huo
Two-year clinical results from the prospective, large-scale, multi-center Firebird-2 cobalt-chromium alloyed sirolimus-eluting stent (FOCUS) registry :
Feng Zhang
Early administration of Tifofiban in high-risk patients with Non-ST elevation acute coronary syndrome referred for elective percutaneous coronary intervention, the ETN-STEP study :
Jianping Li